United States · Exchanges & live quotes · Nasdaq

AstraZeneca Projects $80 Bln In Total Revenue By 2030, Sustained Growth Beyond

Published by Nasdaq · United States 3 h ago

(RTTNews) - British drug major AstraZeneca Plc (AZN, AZN.L) announced that it aims for $80 billion in total revenue by 2030, and sustained growth beyond the year.

Read the full article on Nasdaq Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nasdaq.com)

Also worth reading

OilPrice.com

AstraZeneca Projects $80 Bln In Total Revenue By 2030, Sustained Growth Beyond

Share

Also worth reading

Trump Moves to Ease Methane Regulations for U.S. Oil Producers

Brazilian Stocks Sink After Surprising Presidential Election Result

Latest Monero (XMR) Price Analysis

Tech Sell-Off Leads to Uptick in Defensive Stocks

Introducing new self-learning context enrichment in Knowledge Catalog